Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Envafolimab +/- CAPEOX in locally advanced colorectal cancer
NCT06014372Phase 2Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2023
- Primary completion
- Jul 2024
- Modality
- Nanobodies (VHH), Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of envafolimab in colorectal cancer (CRC), sponsored by Sun Yat-sen University. Started Jul 2023; status: recruiting.
02
Drugs
envafolimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06014372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06014372.